The authors discuss the differences in mechanism of activation of N-nitrosamides versus N-nitrosamines and the fact that they should not be treated the same.
Chuck Lambert
Advertisement
Chuck Lambert, PhD, DABT, ERT is principal toxicologist at Intrinsik Ltd.
Articles by Chuck Lambert
Advertisement
Latest Updated Articles
Nitrosamides–Should They Be Treated the Same as Nitrosamines?Published: October 15th 2022 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Building Resilience in Pharma: Our Top 10 Questions from CPHI Frankfurt
2
Everything to Know About Pharmaceutical Tariffs in 2025
3
Challenges for the Global Manufacturing of Vaccines
4
New Dosage Forms and Delivery Systems Driving 505(b)(2) Success
5
